Evidence map›Paper›PMID 36678699›Full record

ReviewPharmaceutics2022

Cyclotron Production of Gallium-68 Radiopharmaceuticals Using the

Zarif Ashhar, Muhammad Fakhrurazi Ahmad Fadzil, Muhamad Faiz Othman, Nor Azah Yusof, Muhammad Adib Abdul Onny, Noratikah Mat Ail, Siti Fatimah Abd Rahman

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Phase I/IIa clinical trial ofAnnals of nuclear medicine · 2026
    Article
  2. Easy and versatile preparation ofEJNMMI radiopharmacy and chemistry · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. [Current radiopharmaceuticals · 2025
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Zarif AshharPharmacy Department, National Cancer Institute, Putrajaya 62250, Malaysia.ORCID 0000-0001-5057-4705
Muhammad Fakhrurazi Ahmad FadzilPharmacy Department, National Cancer Institute, Putrajaya 62250, Malaysia.ORCID 0000-0003-4675-3078
Muhamad Faiz OthmanFaculty of Pharmacy, Universiti Teknologi Mara, Puncak Alam 42300, Malaysia.ORCID 0000-0002-9024-4548
Nor Azah YusofDepartment of Chemistry, Faculty of Science, Universiti Putra Malaysia, Serdang 43400, Malaysia.
Muhammad Adib Abdul OnnyNuclear Medicine Department, National Cancer Institute, Putrajaya 62250, Malaysia.
Noratikah Mat AilPharmacy Department, National Cancer Institute, Putrajaya 62250, Malaysia.
Siti Fatimah Abd RahmanSchool of Electrical and Electronic Engineering, Engineering Campus, Universiti Sains Malaysia, Nibong Tebal 14300, Malaysia.
National Cancer Institute · MYUniversiti Putra Malaysia · MYUniversiti Sains Malaysia · MYUniversiti Teknologi MARA · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Designing and implementing various radionuclide production methods guarantees a sustainable supply, which is important for medical use. The use of medical cyclotrons for radiometal production can increase the availability of gallium-68 (

Indexed as

cyclotron targetryGood Manufacturing Practices (GMP)liquid targetradiopharmaceuticalsolid target

Identifiers

PMID36678699
PMCPMC9867404
OpenAlexW4313244478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.